Neurology Flashcards
(123 cards)
Signs of Parkinson’s Disease on Examination
Inspection
- Asymmetrical resting tremor: 5Hz (exacerbated by counting backwards)
- Hypomimia (decreased facial expression)
- Extrapyramidal posture
Arms
- Demonstrate bradykinesia
- Tone: cogwheel rigidity
- Enahnced by synkinesis (nvoluntary muscular movements accompanying voluntary movements)
- Normal power and reflexes
- Coordination may be abnormal in multiple system atrophy
Eyes
- Movements:
- nystagmis if multiple system atrophy
- Vertical gaze palsy if progressive supranuclear palsy
- Saccades: slow initiation and movement
Extras
- Glabellar tap (primitive reflex where the eyes shut if an individual is tapped lightly between the eyebrows
- Persistent = myerson’s sign of parkinson’s
- Gait
- Slow initiation
- Shuffling
- Hurrying: festination
- Absent arm swing
- Write sentence, draw spiral
- BP lying and standing (autonomic dysfunction)
Causes of Parkinsonism
Idiopathic Parkinson’s Disease
Parkinson plus syndromes:
- Progressive supranuclear palsy
- Multiple system atrophy
- Lewy body dementia
- Corticobasilar degeneration
Multiple infarcts in the substantia nigra
Wilson’s disease
Drugs: neuroleptics and metoclopramide
Investigations for Parkinsons
Bloods
decreaseed Ceruloplasmisn (Wilson’s Disease)
Imaging
- MRI brain
- Functional neuroimaging (dopamine transporter imaging such as FP-CIT or beta-CIT SPECT, or fluorodopa PET)
Other
- olfactory testing
- genetic testing
Management of Parkinson’s
For first-line treatment:
if the motor symptoms are affecting the patient’s quality of life: levodopa
if the motor symptoms are not affecting the patient’s quality of life: dopamine agonist (non-ergot derived), levodopa or monoamine oxidase B (MAO‑B) inhibitor
1st Line Dopamingeric:
- MAO-B inhibitor
- Dopaminergic agent
2nd-Line dopamingergic
- Amantadine
- Trihexyphenidyl
e. g. rasagiline: 1 mg orally once daily
e. g. carbidopa/levodopa: 50 mg orally (immediate-release) three times daily initially
Physical ativity: resistance training improves motor symptoms
If moderate Parkinson’s OR refractory tremor
Add amantadine, trihexyphenidyl or deep brain stimulation
Add in COMT inhibitor if on cabridopa/levodopa and effects dimishinging e.g. entacapone: 200 mg orally with each dose of carbidopa/levodopa
Drugs to Treat Parkinson’s
Levodopa
- usually combined with a decarboxylase inhibitor (e.g. carbidopa or benserazide) to prevent peripheral metabolism of levodopa to dopamine
- reduced effectiveness with time (usually by 2 years)
- unwanted effects: dyskinesia (involuntary writhing movements), ‘on-off’ effect, dry mouth, anorexia, palpitations, postural hypotension, psychosis, drowsiness
- no use in neuroleptic induced parkinsonism
Dopamine receptor agonists
- e.g. Bromocriptine, ropinirole, cabergoline, apomorphine
- ergot-derived dopamine receptor agonists (bromocriptine, cabergoline) have been associated with pulmonary, retroperitoneal and cardiac fibrosis.
- The Committee on Safety of Medicines advice that an echocardiogram, ESR, creatinine and chest x-ray should be obtained prior to treatment and patients should be closely monitored
- patients should be warned about the potential for dopamine receptor agonists to cause impulse control disorders and excessive daytime somnolence
- more likely than levodopa to cause hallucinations in older patients. Nasal congestion and postural hypotension are also seen in some patients
MAO-B (Monoamine Oxidase-B) inhibitors
- e.g. Selegiline
- inhibits the breakdown of dopamine secreted by the dopaminergic neurons
Amantadine
- mechanism is not fully understood, probably increases dopamine release and inhibits its uptake at dopaminergic synapses
- side-effects include ataxia, slurred speech, confusion, dizziness and livedo reticularis
COMT (Catechol-O-Methyl Transferase) inhibitors
- e.g. Entacapone, tolcapone
- COMT is an enzyme involved in the breakdown of dopamine, and hence may be used as an adjunct to levodopa therapy
- used in conjunction with levodopa in patients with established PD
Antimuscarinics
- block cholinergic receptors
- now used more to treat drug-induced parkinsonism rather than idiopathic Parkinson’s disease
- help tremor and rigidity
- e.g. procyclidine, benzotropine, trihexyphenidyl (benzhexol
Path of Parkinson’s
Destruction of dopaminergic neurons in pars compacta of the substantia nigra
The nerve cell bodies of the pars compacta are coloured black by the pigment neuromelanin - this is lost in Parkinson’s
beta-amyloid plaques
Neurofibriliary tangles: hyperphosphorylated tau
Features of Parkinson’s
TRAPPS PD
Tremor: increased by stress, decreased by sleep
Rigidity: lead-pipe, cog-wheel
Akinesia: slow initiation, difficulty with repetitive movement, micrographia, monotonous voice, mask-like face
Postural instability: stooped gait with festination
Postural hypotension and other autonomic dysfunction
Sleep disturbance
Pyschosis
Depression, Dementia
Sleep disorders in Parkinson’s
Insomnia and frequent waking –> excessive daytime sleepiness
Inability to turn, restless legs, early mornign dystonia (medication wearing off), nocturia, obstructive sleep apnoea
REM behavioural sleep disorder
Loss of muscle atonia during REM sleep –> violent enactment of dreams
Autonomic dysfunction in Parkinson’s
Drugs + neurodegeneration
Postural hypotension
Constipation
Hypersalivation –> dribbling
Urgency, frequency and nocturia
Erectile dysfunction
Hyperhidrosis
L-DOPA side effects
DOPAMINE
Dyskinesia
On-Off phenomena = motor fluctuations
Psychosis
Arterial BP decrease
Mouth dryness
Insomnia
Nausea and vomiting
Excessive daytime sleepiness
Multisystem Atrophy
Papp-Lantos bodies: alpha-synuclein inclusions of glial cells
Autonomic dysfunction: postural hypotension, impotence, loss of sweating, dry mouth and urinary retention and incontinence
AND
Parkinsonism
AND
Cerebellar ataxia
If autonomic features predominate, may be referred to as Shy-Drager syndrome
Progressive Supranuclear Palsy
Tauopathy
Cardinal Features
- Supranuclear ophthalmoplegia
- Neck dystonia
- Parkinsonism
- Pseudobulbar palsy
- Behavioral and cognitive impairment
- Imbalance and walking difficulty
- Frequent falls
Postural instability –> falls
Vertical gaze palsy
Oculocephalic reflex –> involuntary eye movements better
convergence insufficiency
Pseudobulbar palsy: speech and swallowing problems
Parkinsonism: Symmetrical onset, tremor unusual
Corticobasilar Dementia
Neurodegenerative condition affecting the cerebral cortex and basal ganglia
Cardinal features
- Parkinsonism
- Alien hand syndrome
- Apraxia (ideomotor apraxia and limb-kinetic apraxia)
- Aphasia
Unilateral Parkinsonism
Rigidity in particular
Aphasia
Astereognosis: inability to identify an object by active touch of the hands without other sensory input
Due cortical sensory loss —> alien limb phenomenon and automous arm movements
Lewy Body Dementia
Alpha-synuclein and ubitquitin Lewy Bodies in the brainstem and neocortex
Features
Fluctuating cognition
Visual hallucinations
Parkinsonism
Causes of Tremor
Resting:
Parkinsons
Intention:
cerebellar disease
Postural: worse with arms otustretched
- Benign essential tremor
- Endocrine: hyperthyroidism
- Alcohol withdrawal
- Beta-agonists
- Anxiety
Benign Essential Tremor
Autosomal dominant
Occurs with movement and worse with anxiety/ caffeine
Doesn’t occur with sleep
Better with alcohol
Signs of Cerebellar Syndrome on Examination
DANISH
Dydiadochokinesia: hands and feet
Ataxia
Nystagmus + rapid saccades
Intention tremor and dysmetria (lack of coordination of movement typified by the undershoot or overshoot of intended position with the hand, arm, leg)
Slurred speech
Hypotonia/Heel-shin test
Causes of Cerebellar Syndrome
DAISES
Demyelination
Alcohol
Infract: brainstem stroke
SOL e.g. shwannoma + other cerebellopontine angle tumours
Inherited: Wilson’s disease, Friedrich’s ataxia, Ataxia-telangiectasia, Von Hippel Lindau syndrome
Epilepsy
System atrophy, multiple
Vestibular and Cerebellar Nystagmus
Cerebellar cause
Fast phase towards lesion
Maximal looking towards lesion
Vestibular cause
Fast phase looking away from lesion
Maximal looking away from lesion
Lateral Medullary Syndrome / Wallenberg’s
Occlusion of vertebral artery or PICA (posterior inferior cerebellar artery)
—> ischaemia to lateral part of medulla oblongata in the brainstem
Sensory deficits that affect the trunk and extremities contralaterally (opposite to the lesion),
AND
Sensory deficits of the face and cranial nerves ipsilaterally (same side as the lesion)
DANVAH
Dysphagia: damage to nucleus ambiguus –> motor to CN IX and X
Ataxia: damage to inferior cerebellar peduncle
Nystagmus: damage to inferior cerebellar peduncle
Vertigo: damage to vestibular nucleys
Anaesthesia (contralateral): damage to spinothalamic tract
Anaesthesia (ipsilateral): damage to spinal trigeminal nucleus
Horner’s syndrome: damage to sympathetic fibres
Vestibular Schwannoma
Benign slow growing tumout of superior vestibular nerve
SOL —> Cerebellopotine angle syndrome
Assoc with NF type II
Unilateral SNHL
Tinnitus
Vertigo
Increase ICP –> headache
Ipsilateral CN V, VI, VII and VII palsies
Cerebellar signs
Signs:
Facial anaesthesia
Absent corneal reflex
LMN facial nerve palsy
Lateral rectuis palsy
SNHL
DANISH
Cerebellopontine Angle Tumours
Vestibular schwannoma (80%)
Meningioma
Cerebellar astrocytoma
Metastases
Von Hippel-Lindau
Renal cysts
Bilateral renal cell carcinoma
Haemangioblastomas often in cerebellum –> cerebellar signs
Phaeochromocytoma
Islet cell tumours
Friedrich’s Ataxia
Autosomal recessive mitochondrial disorder
Progressive degeneration of the:
Dorsal column
Spinocerebellar tracts and cerebellar cells
Corticosinal tracts
Onset in teenage years
Associated with HOCM and mild dementia
Main features:
Pes cavus
Bilateral cerebellar ataxia
Leg wasting + areflexia but extensor plantars
Loss of vibration and proprioception
Additional Features
High-arched palate
Optic atrophy and retinitis pigmentosa
HOCM: ESM and 4th heart sound
DM